31st Annual TNP Conference Session F18 Evaluation - Early Recognition and Management of Pediatric Sepsis Survey

	Strongly Disagree	Disagree	Agree	Strongly Agree
Discuss the continuum of sepsis including Systemic Inflammatory Response Syndrome (SIRS), sepsis, severe sepsis and septic shock in the pediatric patient	Discuss the continuum of sepsis including Systemic Inflammatory Response Syndrome (SIRS), sepsis, severe sepsis and septic shock in the pediatric patient Strongly Disagree	Discuss the continuum of sepsis including Systemic Inflammatory Response Syndrome (SIRS), sepsis, severe sepsis and septic shock in the pediatric patient Disagree	Discuss the continuum of sepsis including Systemic Inflammatory Response Syndrome (SIRS), sepsis, severe sepsis and septic shock in the pediatric patient Agree	Discuss the continuum of sepsis including Systemic Inflammatory Response Syndrome (SIRS), sepsis, severe sepsis and septic shock in the pediatric patient Strongly Agree
Differentiate between typical and atypical presenting symptoms that may identify sepsis or septic shock. (20 min) 3.Analyze lab results that are used to identify the severity and adequacy of treatment of sepsis/septic shock	Differentiate between typical and atypical presenting symptoms that may identify sepsis or septic shock. (20 min) 3.Analyze lab results that are used to identify the severity and adequacy of treatment of sepsis/septic shock Strongly Disagree	Differentiate between typical and atypical presenting symptoms that may identify sepsis or septic shock. (20 min) 3.Analyze lab results that are used to identify the severity and adequacy of treatment of sepsis/septic shock Disagree	Differentiate between typical and atypical presenting symptoms that may identify sepsis or septic shock. (20 min) 3.Analyze lab results that are used to identify the severity and adequacy of treatment of sepsis/septic shock Agree	Differentiate between typical and atypical presenting symptoms that may identify sepsis or septic shock. (20 min) 3.Analyze lab results that are used to identify the severity and adequacy of treatment of sepsis/septic shock Strongly Agree
Summarize an evidence based recommended treatment plan for septic shock in the pediatric patient.	Summarize an evidence based recommended treatment plan for septic shock in the pediatric patient. Strongly Disagree	Summarize an evidence based recommended treatment plan for septic shock in the pediatric patient. Disagree	Summarize an evidence based recommended treatment plan for septic shock in the pediatric patient. Agree	Summarize an evidence based recommended treatment plan for septic shock in the pediatric patient. Strongly Agree

Strongly Disagree

Disagree

Agree

Strongly Agree

Discuss the continuum of sepsis including Systemic Inflammatory Response Syndrome (SIRS), sepsis, severe sepsis and septic shock in the pediatric patient

Discuss the continuum of sepsis including Systemic Inflammatory Response Syndrome (SIRS), sepsis, severe sepsis and septic shock in the pediatric patient Strongly Disagree

Discuss the continuum of sepsis including Systemic Inflammatory Response Syndrome (SIRS), sepsis, severe sepsis and septic shock in the pediatric patient Disagree

Discuss the continuum of sepsis including Systemic Inflammatory Response Syndrome (SIRS), sepsis, severe sepsis and septic shock in the pediatric patient Agree

Discuss the continuum of sepsis including Systemic Inflammatory Response Syndrome (SIRS), sepsis, severe sepsis and septic shock in the pediatric patient Strongly Agree

Differentiate between typical and atypical presenting symptoms that may identify sepsis or septic shock. (20 min) 3.Analyze lab results that are used to identify the severity and adequacy of treatment of sepsis/septic shock

Summarize an evidence based recommended treatment plan for septic shock in the pediatric patient.

* 6. The content of the program was free of commercial bias.

Strongly Disagree

Disagree

Neither agree nor disagree

Agree

Strongly Agree

Question Title

* 7. Speaker fully disclosed any conflict of interest and discussion of off-label usage of medication and/or medical devices at beginning of, or during the presentation.

Strongly Disagree

Disagree

Agree

Strongly Agree

Strongly Disagree

Disagree

Agree

Strongly Agree

Question Title

* 8. I would recommend this speaker for future conference.

Strongly Disagree

Disagree

No Opinion

Agree

Strongly Agree

Strongly Disagree

Disagree

No Opinion

Agree

Strongly Agree

Question Title

* 1. F18: As a result of my participation in Early Recognition of Management of Pediatric Sepsis, I am better to:

Question Title

* 2. The teaching methods used were appropriate to the objectives.

Question Title

* 3. The presenter demonstrated experiential knowledge of the topic.

Question Title

* 4. The individual objectives/content topic were cohesive with one another.

Question Title

* 5. The content of the program was fair and balanced.

Question Title

* 6. The content of the program was free of commercial bias.

Question Title

* 7. Speaker fully disclosed any conflict of interest and discussion of off-label usage of medication and/or medical devices at beginning of, or during the presentation.

Question Title

* 8. I would recommend this speaker for future conference.